Serum Uric Acid and Lipid Levels While Taking Topiramate for Migraine

Authors

  • Abdulkadir Koçer MD,

    1. From the Neurology, Düzce Medical Faculty, Düzce University, Düzce, Turkey (A. Koçer, S. Atakay, and inline image. Okuyucu); Neurology, Düzce Atatürk State Hospital, Düzce, Turkey (S. Dikici).
    Search for more papers by this author
  • Süber Dikici MD,

    1. From the Neurology, Düzce Medical Faculty, Düzce University, Düzce, Turkey (A. Koçer, S. Atakay, and inline image. Okuyucu); Neurology, Düzce Atatürk State Hospital, Düzce, Turkey (S. Dikici).
    Search for more papers by this author
  • Selcuk Atakay MD,

    1. From the Neurology, Düzce Medical Faculty, Düzce University, Düzce, Turkey (A. Koçer, S. Atakay, and inline image. Okuyucu); Neurology, Düzce Atatürk State Hospital, Düzce, Turkey (S. Dikici).
    Search for more papers by this author
  • Efika Okuyucu MD

    1. From the Neurology, Düzce Medical Faculty, Düzce University, Düzce, Turkey (A. Koçer, S. Atakay, and inline image. Okuyucu); Neurology, Düzce Atatürk State Hospital, Düzce, Turkey (S. Dikici).
    Search for more papers by this author

  • Conflict of Interest: None

A. Koçer, Neurology, Düzce Medical Faculty, Düzce University, Konuralp, Düzce 8100, Turkey.

Abstract

Objective.— Topiramate (TPM) therapies for epilepsy or migraine are long-time therapies with unknown mechanisms and special side effects. TPM influences cholesterol (TC) and lipoprotein serum levels. In addition, TPM may cause uric acid (UA) stone formation.

Material and Methods.— Serum UA, TC, and triglyceride (TG) levels were measured in 53 migraine patients receiving TPM and in 44 age- and sex-matched controls. Compared with controls, patients on TPM showed significantly higher UA and nonsignificantly higher TC and TG values. We recorded pre- and posttreatment levels of UA, TC, and TG levels in 23 patients.

Results.— We found increased serum levels of UA with TPM use (P < .01). There was a significant and positive correlation between serum UA levels and male gender (P < .01).The changes in serum UA levels before and after TPM treatment differed significantly (P < .01).

Conclusion.— Our results suggest a need for monitoring serum UA levels in patients receiving TPM. We should perhaps prescribe a low-UA diet and advice to drink much more water in these patients.

Ancillary